IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In Re:
`
`U.S. Patent of Navarro et al.
`
`Proceeding No.:
`
`IPR2016-00075
`
`Patent No.:
`
`7,297,703
`
`Application No.:
`
`11/020,860
`
`For:
`
`MACROLIDES
`
`PATENT OWNER’S POWER OF ATTORNEY IN AN INTER PARTES REVIEW
`
`Patent Owner Novartis AG (“Novartis”) hereby appoints Nicholas N. Kallas (Reg.
`
`No. 31,530) and Raymond R. Mandra (Reg. No. 34,382) as its attorneys to prosecute the
`
`aforementioned proceeding and to transact all business in the United Patent and Trademark
`
`Office connected therewith.
`
`Please address all correspondence as follows:
`
`Nicholas N. Kallas
`
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 10104-3800
`Telephone: (212) 218-2100
`Facsimile: (212) 218-2200
`n1<a1las@fchs.com
`
`Dated: November 9, 2015
`
`
`
`.
`
`C ,
`
`
`
`
`Andrea Jacquin
`Novartis Pharmaceuticals Corporation
`One Health Plaza
`
`
`
`
`
`Novartis Pharmaceuticals Corporation
`One Health Plaza
`
`East Hanover, NJ 07936-1080
`
`East Hanover, NJ 0793 6-1080
`
`gwitnessedby:
`ARE
`
`Signature
`
`Printed name
`
`0/PD“/t~Q_l\_
`
`Witnessedby:
`
`
`Printed name
`
`

`
`
`
`-..,.._
`-I-H"
`
`Power of Attorney
`(To Novartis IP colleagues based in US, IT, DE, SG, CN)
`
`By this Power of Attorney, effective Ol January 2015, Novartis AG, a company
`incorporated under the laws of Switzerland and having its principal place of business at
`Lichtstrasse 35, 4056 Basel. Switzerland (“the Company"), hereby grants to the Novartis
`Group Companies listed below (“the C otporate Signatories"]:
`
`a)
`
`b)
`
`C)
`
`the revocable authority to sign documents on behalf of the Company in
`connection with tiling, prosecution, maintenance, and administration of any
`intellectual property right
`for
`copyright,
`design,
`domain name,
`patent,
`supplementary protection certificate (SPC) and trademark registration or any
`application therefore standing in the name ofthe Company ("‘lP“_);
`
`the revocable authority to sign documents on behalf of the Company in
`connection with litigation relating to defense of ll’ before a gox-'ernmental
`authority: and
`
`the revocable authority to sign Conlirmatory Assignments on behalf of the
`Company.
`“Contirmatory Assignments" are agreements between the Company
`and a third party or a Novartis Group entity that do not create new rights or
`obligations for the Company, such rights having been created by an underlying
`agreement (e.g. acquisition/divestment agreement, research funclingfcollaboration
`agreement, and the like) and whereby the Confirmatory Assignment merely
`executes the transfer of'lP as agreed in such underlying agreement;
`
`and for no other purposes.
`
`This Power of Attorney excludes the power to conclude contracts, other than
`Confirm-atory Assignments, or to enter into settlements on behalf of the Company.
`The
`terms
`“contracts”
`and
`“settlements”
`include
`license
`agreements,
`acquisition/divestment agreements. assignments, prior right agreements and/or letters of
`consent.
`
`This Power of Attorney includes the power to appoint external agents within the scope of
`this Power of Attorney.
`
`To be legally binding upon the Company, all relevant documents require the signature of
`two employees of the Corporate Signatory as set out below (“Personal Signatories”)
`authorized to sign for the respective Corporate Signatory, except where a single Personal
`Signatory is permitted according to the Novartis internal “Intellectual Property Signature
`Guidelines” .
`
`»
`
`.
`‘
`
`

`
`
`Corporate Signatories
`Personal Signatories
`
`Alcoa Laboratories, Inc.
`
`Aieon Research, Ltd.
`
`Catherine D. Murray
`Christianne K. Garrow
`
`Denise C. Vivar
`
`Mary Lozano
`Stephanie J. Boyle
`Sheldon R. Pontaoe
`
`Barbara McKenzie
`Barry L. Copeland
`Candy Sanders
`Christine Bohmann
`Darden Weiss
`Darien L. Redclick
`Deborah Weinschenk
`Deena Nutt
`
`Gergeiy T. Zimanyi
`Glenda Wolfe
`Jason Finch
`
`Jason .1. Derry
`Jian Zhou
`
`Jonathan E. Prejean
`Keiko Ichiye
`Kelly Bryant
`Kenneth D. Bassinger
`Mark E. F lanigan
`Martha E. Martin
`Michael Rein
`
`Patrick M. Ryan
`Robert Ambrose
`Russell E. I-Ienrichs
`
`Matthew A. I-Iayenga
`Scott A. Chappie
`Sheldon R. Pontaoe
`
`Shelley Rose
`Sheng Hu
`Sue Stockton
`
`Tracy I-lumphreys
`
`Novartis Healthcare Private Limited
`
`Atul Bade
`
`Ashish Jo gi
`
`Novartis Vaccines and Diagnostics Gmbll
`
`Graham Wilkinson
`
`
`
`.
`
`i.L.
`
`.
`
`1
`
`

`
`Personal Signatories
`Corporate Signatories
`
`Novastis Vaccines and Diagnostics, S.i'.i.
`
`Sancloz International Gmbl-I
`
`Novartis Animal Health US, Inc.
`
`Novartis Consumer Health, Inc.
`
`Novanis Vaccines and Diagnostics, Inc.
`
`Antoine Courgeon
`Catherine Paula Sampson
`Stephen Evans
`Ilaria Ferrarini
`Marta Palla
`
`Stephanie Odette Belbeoc'h
`
`Andrzej Czopelc
`Andrea Felbermeir
`Britta Chamberlain
`
`[ris lieinrichsberger
`Manuela Hillewaert
`Meike Urban
`Susanne Groeschel~Jofer
`
`Tanya Fickenscher—LeonarcE
`Tirno Getting
`
`Clint Vranian
`Delisa Daniels
`
`Jennifer Story
`
`Alison Kessler
`Beth Nussbaum
`Diane Furrnan
`
`Greg Tole
`Mary Cheli
`Mary Leheny
`Nazuki Hughes
`Maria Siachura
`
`Amy Olinger
`Atsuko N. Polzin
`Beth O'Brien
`
`Cynthia Chen
`Helen Lee
`Joanna Burns
`John Ward
`
`Juerg Baenziger
`Kathleen Bastarache
`Nlarco Riensche
`Nicholas J. Finnie
`Norma Gallina
`
`

`
`
`
`Corporate Signatories
`
`Personal Signatories
`
`Novartis Corporation
`
`Betty Ryberg
`
`Novartis Institutes for BioI\/ledical Research,
`Inc.
`
`Adam Poulindierstein
`Arlene Mussel‘
`
`David Carpenter
`Frank Wu
`Grace Law
`Helen Kim
`
`Jasbir Sagoo
`Jean Silveri
`John B. Alexander
`John Prince
`Jonathan Wood
`Joshua Roth
`Laura Madden
`Lisa Alexander
`Lisa Nash
`Mei Benni
`Melissa Ponziano
`i\/iichael G. Smith
`
`Paul Paglierani
`Qian Zhang neat]
`Robert Sweeney
`Rona Nardone
`
`Safiya Watson
`Scott Brown
`Scott Reid
`
`Sophie Binet Cross
`Stephen Johnson
`Susan Dillon
`
`Chihang Amy Smith
`Daniel E. Raymond
`Emily Tongco—Wu
`Jill R. Clarke
`
`Julie McCarthy
`Kerri Pollard Schray
`Susan Sesnovich
`
`Frank Kaul
`Frank Hauerken
`Jan—Thore Fohrenbach
`
`Novartis Institute for Functional Genomies,
`lne.
`
`CIBA VISION Vertriebs Gmbl-I
`
`

`
`
`
`>
`
`
`Corporate Signafories
`Personal Sign atories
`
`Novartis Pharmaceuticals Corporation
`
`Andrea J acquin
`Andrew Holmes
`Annette Cromer
`Christine McCormecl<
`
`Cindy Klepacky
`Cozette 1VlCAVO}"
`Daniel Woods
`
`David Kurlandsky
`Denise Cooper
`Diane Leone
`
`Gregory Ferraro
`Gregory Houghton
`Jennifer Chapman
`Jim Lynch
`Kelly Striienberger
`Leslie Fischer
`Linda Adams
`Lisa Matovcik
`
`Lydia McNally
`Marie Collazo
`Mark Seka
`Matthew Mulkcen
`l\/Iaureen McGee
`
`Mahdi Ganjeizadeh
`Michael Mazza
`Oswaldo Lecuona
`Peter Waibei
`Sandra Rueck
`Sherri Rose
`
`Sudipta Rao
`Sveilana Korzhin
`
`

`
`
`
`
`Corporate Signatories
`Persona} Signatories
`
`Novartis Institute for Tropical Diseases Pie.
`Ltcl.
`
`Yotmbeen Kim
`
`Beijing Novartis I’l1arma Co. Ltd.
`
`Fan (Kent) Yang [lfiifilllil]
`Zheng (Aileen) Wei [§93_%§]
`Wen (Lucia) Tang [E373]
`Juan (Jane) Ye {l1‘l'§tE=i}
`Xiaoning (Remy) Wang [E1'i\$]
`
`Novartis Services Incorporated
`
`Frank Smith
`
`ChinaNovartis Institutes for Bi0Medical
`
`John T. Li
`
`Research Ca, Ltd.
`
`Sing Sun
`
`is valid until 3i December 3015 and replaces all prexrious
`This P0wer—0f—Att0rne}'
`versions of Powers of Attorney relating to the subject matter herein.
`
`Basel, l0 December 2014,
`
`NOVARTIS AG
`
`
`
`Authorized Si gnatcry
`
`Authorized Signatory
`
`Alisa Harbin
`
`Authorized Signatory
`
`3*‘ ‘-’"VeF 35- Brupbacher
`Attorney at Law, LL,M_
`
`

`
`ATTESTATION
`
`E,
`
`the undersigned Civil Law Notary in Basel, Switzerland, Mathias Kuster, certify
`
`herewith that the signatures attached heretofore are the genuine signatures of M5.
`
`Alisa Harbin, citizen of
`the United States of America,
`residing in Reinach BL,
`‘:._‘Switzerland; and of Dr. Oiiver Mark Brupbacher, citizen of Wadenswil, Switzerland,
`\\ ‘residing
`in Feusisberg, Switzerland;
`both acting for Novartis AG,
`in Basel,
`'\,‘S?'r;tzerland, both as authorized signatories and both with joint signature.
`.,‘
`‘In
`‘E
`'\
`i"= aifigenticity of the signatures was established by means of comparison.
`"5
`x
`\
`V.
`BASEt‘,:\Swi'i:I_erland, this 12"’ (twelfth) day of December 2014 (two thousand and fourteen)
`K
`'-s.
`
`"'\\“
`-.3“
`
`‘A.‘:‘
`‘
`‘Kw
`
`'4 7
`
`_
`
`--
`
`5/
`
`t. "’
`
`.a-"a3{:",.'«'—f’
`
`; ‘fr r‘
`
`V
`1.
`x
`H.
`\
`\
`x‘
`‘g
`\
`\
`1
`
`i\
`s
`‘
`i
`‘3
`;
`i
`x
`x
`\
`\
`
`\ i
`
`\i
`
`i\\
`
`4-—
`Leg.Prot.l\Ir. %~
`
`.1. A /2014